These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 23651436)

  • 41. Bridging the resource gap: improving value for money in HIV/AIDS treatment.
    Soni A; Gupta R
    Health Aff (Millwood); 2009; 28(6):1617-28. PubMed ID: 19887403
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Health expenditure and finance: who gets what?
    Doherty J; McIntyre D; Bloom G; Brijlal P
    Bull World Health Organ; 1999; 77(2):156-9. PubMed ID: 10083715
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The structure of South Africa's health service.
    Zwarenstein M
    Afr Health; 1994 Mar; (Spec No):3-4. PubMed ID: 12345506
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The impact of the HIV/AIDS epidemic on hospital nurses in KwaZulu Natal, South Africa: nurses' perspectives and implications for health policy.
    Zelnick J; O'Donnell M
    J Public Health Policy; 2005 Jul; 26(2):163-85. PubMed ID: 16022210
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The impact of Global Health Initiatives at national and sub-national level - a policy analysis of their role in implementation processes of antiretroviral treatment (ART) roll-out in Zambia and South Africa.
    Hanefeld J
    AIDS Care; 2010; 22 Suppl 1():93-102. PubMed ID: 20680864
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Optimizing resource allocation for HIV/AIDS prevention programmes: an analytical framework.
    Bautista-Arredondo S; Gadsden P; Harris JE; Bertozzi SM
    AIDS; 2008 Jul; 22 Suppl 1():S67-74. PubMed ID: 18664956
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Distinguishing government's responsibility in rationing public and private medical resources.
    Blumstein JF
    Tex Law Rev; 1982 May; 60(5):899-918. PubMed ID: 11650651
    [No Abstract]   [Full Text] [Related]  

  • 48. National expenditure on health research in South Africa: what is the benchmark?
    Paruk F; Blackburn JM; Friedman IB; Mayosi BM
    S Afr Med J; 2014 May; 104(7):468-74. PubMed ID: 25214045
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Diplomacy and Health: The End of the Utilitarian Era.
    Kevany S; Matthews M
    Int J Health Policy Manag; 2017 Apr; 6(4):191-194. PubMed ID: 28812802
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Ethical issues in the transformation of health policy in South Africa.
    Pillay YG
    S Afr Med J; 1992 Jul; 82(1):32-4. PubMed ID: 1641719
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Financing structural interventions: going beyond HIV-only value for money assessments.
    Remme M; Vassall A; Lutz B; Luna J; Watts C
    AIDS; 2014 Jan; 28(3):425-34. PubMed ID: 24670525
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Claims on health care: a decision-making framework for equity, with application to treatment for HIV/AIDS in South Africa.
    Cleary SM; Mooney GH; McIntyre DE
    Health Policy Plan; 2011 Nov; 26(6):464-70. PubMed ID: 21186205
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Economic Evaluation in Ethiopian Healthcare Sector Decision Making: Perception, Practice and Barriers.
    Zegeye EA; Mbonigaba J; Kaye SB; Wilkinson T
    Appl Health Econ Health Policy; 2017 Feb; 15(1):33-43. PubMed ID: 27637919
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Wellness programme and health policy development at a large faith-based organisation in Khayelitsha, South Africa.
    Arend ED
    Afr J AIDS Res; 2008 Nov; 7(3):259-70. PubMed ID: 25875454
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Global health diplomacy, 'smart power', and the new world order.
    Kevany S
    Glob Public Health; 2014; 9(7):787-807. PubMed ID: 24953683
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Designing equitable antiretroviral allocation strategies in resource-constrained countries.
    Wilson DP; Blower SM
    PLoS Med; 2005 Feb; 2(2):e50. PubMed ID: 15737005
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Allocating HIV-prevention resources: balancing efficiency and equity.
    Kaplan EH; Merson MH
    Am J Public Health; 2002 Dec; 92(12):1905-7. PubMed ID: 12453805
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pharmacogenetic interventions, orphan drugs, and distributive justice: the role of cost-benefit analysis.
    Rai AK
    Soc Philos Policy; 2002; 19(2):246-70. PubMed ID: 12678089
    [No Abstract]   [Full Text] [Related]  

  • 59. The influence of constraints on the efficient allocation of resources for HIV prevention.
    Stopard IJ; McGillen JB; Hauck K; Hallett TB
    AIDS; 2019 Jun; 33(7):1241-1246. PubMed ID: 30649065
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Equitable rationing of highly specialised health care services for children: a perspective from South Africa.
    Landman WA; Henley LD
    J Med Ethics; 1999 Jun; 25(3):224-9. PubMed ID: 10390676
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.